MLYS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is -0.961, suggesting MLYS is Strong Sell.

Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 28.351, while Mineralys Therapeutics Inc (MLYS) share price is $27.97, making it Sell.

Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 32.044, while Mineralys Therapeutics Inc (MLYS) share price is $27.97, making it Sell.

Technical Analysis for MLYS

Technical Sentiment Analysis for Mineralys Therapeutics Inc (MLYS) As of 2026-03-11, Mineralys Therapeutics Inc (MLYS) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 10 technical signals, shows that 2 indicators are flashing buy, while 8 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for MLYS stands at 43.365, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.961, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 50.509 and the Commodity Channel Index (CCI) at -48.038 further confirm a -1.26 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, MLYS is trading above its 60-day moving average of $32.044 and above its 200-day long-term moving average of $28.842. Key price levels to watch include the immediate resistance at $31.333 and strong support at $24.703. A break above $31.333 could signal a bull continuation, while falling below $24.703 may test the next Fibonacci floor at $21.221.

Mineralys Therapeutics Inc (MLYS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	18.073	21.221	24.703	27.851	31.333	34.481	37.963
Fibonacci	21.221	23.754	25.319	27.851	30.384	31.949	34.481

Mineralys Therapeutics Inc (MLYS) Technical Indicators

2026-03-11

Name	Value
RSI_14	43.365
STOCHk_14_3_3	50.509
STOCHd_14_3_3	36.855
CCI_20	-48.038
AO_5_34	-2.346
MOM_10	-1.26
MACD_12_26_9	-0.961

Mineralys Therapeutics Inc (MLYS) Relative Strength Index (RSI) is 43.365, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Stochastic Oscillator is 50.509, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Stochastic RSI is 36.855, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Commodity Channel Index (CCI) is -48.038, creating a Neutral signal.

Mineralys Therapeutics Inc (MLYS) Awesome Oscillator is -2.346, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) Momentum is -1.26, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) MACD is -0.961, creating a Sell signal.

Mineralys Therapeutics Inc (MLYS) Moving Average

2026-03-11

Period	Simple	Signal
MA_5	27.39	Buy
MA_10	28.184	Sell
MA_20	28.351	Sell
MA_60	32.044	Sell
MA_200	28.842	Sell
MA_250	25.986	Buy

Mineralys Therapeutics Inc (MLYS) 5-Day simple moving average is 27.39, while Mineralys Therapeutics Inc (MLYS) share price is $27.97, making it a Buy.

Mineralys Therapeutics Inc (MLYS) 10-Day simple moving average is 28.184, while Mineralys Therapeutics Inc (MLYS) share price is $27.97, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 20-Day simple moving average is 28.351, while Mineralys Therapeutics Inc (MLYS) share price is $27.97, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 60-Day simple moving average is 32.044, while Mineralys Therapeutics Inc (MLYS) share price is $27.97, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 200-Day simple moving average is 28.842, while Mineralys Therapeutics Inc (MLYS) share price is $27.97, making it a Sell.

Mineralys Therapeutics Inc (MLYS) 250-Day simple moving average is 25.986, while Mineralys Therapeutics Inc (MLYS) share price is $27.97, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for MLYS?

The overall technical consensus for Mineralys Therapeutics Inc (MLYS) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 0 buy signals and 4 sell signals.

What are the key support and resistance levels for Mineralys Therapeutics Inc (MLYS) today?

Based on pivot point calculations, Mineralys Therapeutics Inc (MLYS) has an immediate support level at 24.703 and a major resistance level at 31.333. Traders also monitor the pivot point at 27.851 to determine the intraday trend direction.

Is Mineralys Therapeutics Inc (MLYS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Mineralys Therapeutics Inc (MLYS) is currently 43.365. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Mineralys Therapeutics Inc (MLYS)?

Mineralys Therapeutics Inc (MLYS) Moving Averages Convergence Divergence (MACD) indicator is -0.961, suggesting MLYS is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Mineralys Therapeutics Inc.

How is Mineralys Therapeutics Inc (MLYS) performing relative to its 200-day moving average?

Mineralys Therapeutics Inc (MLYS) is currently trading at $27.97, which is below its 200-day simple moving average of 28.842. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.